The costs of the consultation meeting and the examinations that aim to find the cause of the infertility are services of the statutory health insurance companies. Hormonal therapies for the woman for the support of ovum maturation are covered completely by statutory health insurance. Since 1 January 2004, at least half of the costs of insemination or IVF/ICSI treatments are covered and some health insurance companies cover them completely. In the consultation meeting, the costs in each individual case are explained.
If needed, we will assist in communications with the health insurance companies.
Additionally, we offer the opportunity of paying my instalments.
At least 50 percent of the treatment and drug costs for a total of:
- eight cycles of insemination in spontaneous cycles
- three cycles of insemination with hormonal stimulation and
- three cycles of an IVF/ICSI treatment.
Requirements for the assumption of 50 percent of the costs
- The woman must be at least 25 years old and no older than 39 .
- The man must be no older than 49 years.
- The couple must be married to each other.
- Before the start of treatment, a written declaration (which is known as a treatment plan) must be submitted to the health insurance company. You receive this treatment plan from us.
- If a clinically proven pregnancy occurs within the approved treatment attempts, the claim exists for the assumption of 50 percent of the costs of a further treatment.
- If a child is born due to treatment, there is a new claim to all services.
- Cryopreservation (freezing) of fertilised ova, sperm, or testicular tissue is not a service covered by statutory health insurance companies.
Contracts with private health insurance companies are not uniform. In general, the application to the insurance company for the assumption of costs must be made in the name of the partner who is the cause of the infertility. We will assist in providing you the proper applications to file after the treatment method has been determined. We recommend submitting the application in advance to that the costs can be clarified before the tart of treatment.
Self-payers are couples who do not meet the requirements for statutory health insurance companies to cover 50 percent of the costs, couples from outside Germany, or also privately insured persons whose private health insurance company does not cover the assumption of costs.
Under certain circumstances the costs can be tax deductible.
For members of statutory insurance companies, the conditions from the regulations in Section 27a SGB V and further guidelines apply. Before treatment, a treatment plan must be submitted to the health insurance company. The partners must be married to each other. There are also age limits. Both partners must be have passed their 25th birthday. The woman must not have reached her 40th birthday or the man his 50th birthday. 50% of the costs will be covered for a maximum of three attempts of IVF or ICSI treatment or for eight inseminations. It is crucial that the principle person applies. This means that a health insurance company reimburses only those costs that arise for the treatment of its insured member. The insurance of the partner is not valid.
For privately insured persons, the specific insurance contract is decisive. The specific Terms and Conditions of Insurance and the tariff conditions govern whether, and to which extent, costs in the field of “artificial insemination” are reimbursed. It is imperative to review these. As a general rule, no prior approval is necessary. The partners do not need to be married to each other. The causation principle applies. This means that, in addition to other requirements, the health insurance company is only obligated to reimburse fees if the insured person causes need for the treatment. In this, case, as a general rule, 100% of the treatment costs will be reimbursed, if certain chances of success are given. To this end, the BGH has judged that a medical probability of 15% must be given. As long as this is given, in many cases the number of attempts is not limited.
For persons entitled to financial aid, the regulations in the aid rules of the individual States and of the Federal Republic apply, as well as their administrative regulations. All financial aid ordinances take the view that the regulations in Section 27a SGB should apply. In this way, financial aid can be viewed in principle as being like a statutory health insurance company with the specified regulations in Section 27a SGB V.
Fertility treatment is recognised as a medically necessary treatment and is not rejected because the fitness of police officers and soldiers to serve is not affected. The Federal Administrative Court has decided that in principle the State aid law is to be applied.
As a general rule, a taxpayer can receive a reduction of income tax based on the costs of their fertility treatments. According to the jurisdiction of the Federal Finance Court, the costs of a couple who cohabit without being married and the costs of heterologous treatment with donor semen are also recognised.
Due to the different derivations of the reimbursement of costs, problems arise mostly when“mixed circumstances”are present. This applies if both partners are not insured by the same health insurance company or if one partner has statutory health insurance and the other has private health insurance. In this case, the rigid rules in Section 27a BGB V clash with the private system of the causation principle and the prospects of success. If one partner is additionally entitled to aid, then claims arise against several payers,which should be known. The network requires an individual assessment in every case.
The contributory causation of the need for fertility treatment by both partners should be checked. In many cases, private health insurance companies claim that their insured member was not the cause of the treatment. However, this does not necessarily mean that the other partner has absolutely no chance.
The most frequent problems arise due to a private health insurance company’s claim that the there is no indication for treatment, the other partner is the cause, or the chances of success are lower than 15%. Also, the AMH value is used or, recently, also the evaluation of the spermiogram. Here, medicine and the law must work together on the basis of the specific findings.
It must be borne in mind that the referral to another insurance company is against the law. The BGH and the BSG have judged that one insurance company cannot make its reimbursement of costs dependent on the services of another insurance company. For this purpose no health insurance company can demand information and documents about the
The costs of cryopreservation (i.e. for freezing ova) are categorically not reimbursed because it does not constitute a treatment. However, there are a few exceptions from this principle.
The treatment costs of heterologous treatment with donor semen are, at present, not reimbursed by either the statutory health insurance companies or by private health insurance. The heterologous treatment with donated ova is forbidden by the ESchG.
The health insurance companies cannot interfere with the medical planning of the treatment . This is in the hands of the couple, together with the doctors, and is based on the specific medical findings.
This representation serves as an initial general introduction to the topic. An individual assessment is recommended.